ISRG vs PFE
ISRG: Intuitive Surgical designs and manufactures robotic-assisted surgical platforms that enable minimally invasive procedures with superior precision and clinician control. PFE: Global biopharmaceutical company discovering, developing, and manufacturing prescription medicines and vaccines across oncology, immunology, cardiovascular, and infectious disease.
Side-by-side fundamentals
| Metric | ISRG | PFE | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $411.55 | $24.25 | |
| Market cap as of 2026-07-10 | $145.7B | $138.1B | |
| P/E as of 2026-07-10 | 48.90 | 18.44 | PFE lower |
| PEG as of 2026-07-10 | 2.97 | -3.38 | PFE lower |
| Net margin as of 2026-07-10 | +28.1% | +11.8% | ISRG higher |
| Gross margin as of 2026-07-10 | +66.3% | +74.8% | PFE higher |
| Operating margin as of 2026-07-10 | +30.4% | +15.4% | ISRG higher |
| ROE as of 2026-07-10 | +17.0% | +8.4% | ISRG higher |
| ROA as of 2026-07-10 | +14.9% | +3.6% | ISRG higher |
| Debt / equity as of 2026-07-10 | 0.00 | 0.72 | ISRG lower |
| Revenue growth (YoY) as of 2026-07-10 | +21.4% | +1.4% | ISRG higher |
| Revenue CAGR (3y) SEC XBRL | +17.4% | -14.8% | ISRG higher |
| Dividend yield as of 2026-07-10 | n/a | +7.1% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-10 | 1.46 | 0.29 | |
| 1-year return as of 2026-07-09 close | -22.1% | -5.1% | PFE higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.